CORT icon

Corcept Therapeutics
CORT

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$85
141% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Swayampakula Ramakanth
44% 1-yr CORT win rate
25 Feb ‘26 6 days ago
Canaccord Genuity
Canaccord Genuity
Edward Nash
50% 1-yr CORT win rate
23 Jan ‘26 1 month ago
UBS
UBS
Ashwani Verma
16 Dec ‘25 2 months ago